Results 1 to 10 of about 11,815 (206)

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma

Türk Oftalmoloji Dergisi, 2012
Pur po se: To evaluate the effects of latanoprost/timolol maleate and dorzolamid/timolol maleate fixed combinations on-24 hours intraocular pressure in patients with open-angle glaucoma.
Berna Yüce, Suzan Güven Yılmaz, Kutay Andaç, Halil Ateş   +3 more
doaj   +2 more sources

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/ timolol among patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2013
Ana Sanseau,1 Juan Sampaolesi,2 Emilio Rintaro Suzuki Jr,3 Joao Franca Lopes,4 Hector Borel51Instituto de la Visión, Ciudad de Buenos Aires, Argentina; 2Consultorio Oftalmologico Sampaolesi, Ciudad de Buenos Aires, Argentina; 3Oftalmoclinica ...
Sanseau A, Sampaolesi J, Suzuki Jr ER, Lopes JF, Borel H   +4 more
doaj   +1 more source

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

Clinical Ophthalmology, 2015
Dietmar Schnober,1 Douglas A Hubatsch,2 Maria-Luise Scherzer3 1Private Ophthalmology Practice, Werdohl, Germany; 2Alcon Laboratories, Inc., Fort Worth, TX, USA; 3Private Ophthalmology Practice, Regenstauf, Germany Purpose: To determine the efficacy and
Schnober D, Hubatsch DA, Scherzer ML
doaj   +1 more source

Association between Ophthalmic Timolol and Hospitalisation for Bradycardia

Journal of Ophthalmology, 2015
Introduction. Ophthalmic timolol, a topical nonselective beta-blocker, has the potential to be absorbed systemically which may cause adverse cardiovascular effects.
Nicole L. Pratt, Emmae N. Ramsay, Lisa M. Kalisch Ellett, Tuan A. Nguyen, Elizabeth E. Roughead   +4 more
doaj   +1 more source

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2008
Douglas J Rhee1, James H Peace2, Sushanta Mallick3, Theresa A Landry3, Michael VW Bergamini3, and the Study Group*1Massachusetts Eye and Ear Infirmary, Harvard University, Boston, MA, USA; 2Diabetic Eye Medical Clinic, Inglewood, CA, USA; 3Alcon ...
Douglas J Rhee, James H Peace, Sushanta Mallick, Theresa A Landry, Michael VW Bergamini, the Study Group*   +5 more
doaj  

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog

Clinical Ophthalmology, 2015
Yoshie Shimizu,1 Shunsuke Nakakura,1 Makiko Nishiyama,1 Hitoshi Tabuchi,1 Yoshiaki Kiuchi2 1Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, 2Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences ...
Shimizu Y, Nakakura S, Nishiyama M, Tabuchi H, Kiuchi Y   +4 more
doaj  

Quantification method for timolol from in vivo samples for the development of a new glaucoma drug depot

Current Directions in Biomedical Engineering, 2018
Glaucoma is the second most common cause of blindness. An increased intraocular pressure is the only treatable symptom of glaucoma. Because patients often exhibit a poor therapy adherence, a drug depot consisting of ELA-NCO and hyaluronic acid with ...
Eickner Thomas, Kopp Franziska, Brietzke Andreas, Kischkel Sabine, Oschatz Stefan, Schmitz Klaus-Peter, Guthoff Rudolf, Grabow Niels   +7 more
doaj   +1 more source

Patient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

Clinical Ophthalmology, 2012
Graham Anthony Auger, Mathew Raynor, Simon LongstaffOphthalmology Department, Royal Hallamshire Hospital, Sheffield, South Yorkshire, United KingdomBackground: This study aimed to determine the impact of switching patients requiring multiple drug ...
Auger GA, Raynor M, Longstaff S
doaj  

"Effect of topical timolol on intraocular pressure in the presence of systemic indomethacin in normal subjects"

Indian Journal of Ophthalmology, 1988
In the present study on 60 normal subjects, the effect of 0.5% timolol eye drops on intraocular tension was assessed in the presence of oral indomethacin. The subjects were categorized in four groups for comparing the results.
Sud R, Malhotra Ajay
doaj  

Corrigendum

Clinical Ophthalmology, 2011
Teus MA, Miglior S, Laganovska G, et al.Efficacy and safety of travoprost/ timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol.
Teus MA, Miglior S, Laganovska G, Volksone L, Romanowska-Dixon B, Gos R, Holló G; for the C-05-25 Study Group   +6 more
doaj